Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease through the analysis of telomeres, today ...
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human ...
Cross-species functional genomics identify ribosomal protein genes as key regulators of cardiomyocyte proliferation and heart development, implicating them as candidate modifiers for HLHS and ...
Kidney diseases, including chronic kidney disease (CKD) and acute kidney injury (AKI), represent a major global public health burden. These diseases cause ...
According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...
Circular Genomics, a leader in circular RNA (circRNA) biomarkers for precision neurology and psychiatry, today announced the appointment of two highly distinguished pioneers in Alzheimer's disease ...
The Functional Genomics Screening Laboratory (FGSL) at the Milner Therapeutics Institute won an OBN Award in the Most ...
The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback